Nanopath Overview
- Year Founded
-
2019
- Status
-
Private
- Employees
-
29
- Latest Deal Type
-
Series B
- Latest Deal Amount
-
$29.9M
- Investors
-
20
Nanopath General Information
Description
Developer of a molecular diagnostic platform designed to enable point-of-care disease diagnosis. The company's technology eliminates the need for nucleic acid amplification and supports multiplexed detection, enabling patients and providers to access actionable diagnostic results within standard office visits for improved healthcare outcomes.
Contact Information
Website
www.nanopath.comCorporate Office
- 750 Main Street
- Cambridge, MA 02139
- United States
Corporate Office
- 750 Main Street
- Cambridge, MA 02139
- United States
Nanopath Timeline
Nanopath Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 18. Later Stage VC (Series B) | 10-Nov-2026 | $29.9M | Completed | Product Development | ||
| 17. Grant | 10-Nov-2026 | Completed | Product Development | |||
| 16. Grant | 30-Jun-2025 | Completed | Product Development | |||
| 15. Later Stage VC | 06-Feb-2025 | Completed | Product Development | |||
| 14. Grant | 01-Sep-2024 | Completed | Product Development | |||
| 13. Grant | 01-Mar-2024 | Completed | Product Development | |||
| 12. Grant | 01-Sep-2023 | Completed | Product Development | |||
| 11. Accelerator/Incubator | 01-Apr-2022 | Completed | Product Development | |||
| 10. Grant | 24-Apr-2023 | $10K | $11M | Completed | Product Development | |
| 9. Accelerator/Incubator | 22-Dec-2022 | $11M | Completed | Product Development |
Nanopath Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Series B 3 | ||||||||
| Series B 2 | ||||||||
| Series B 1 | ||||||||
| Series A 2 | ||||||||
| Series A 1 | 960,984 | $0.000010 | 8% | $1.04 | $1.04 | 1x | $1.04 | 5.66% |
| Series A | 2,495,940 | $0.000010 | 8% | $4.01 | $4.01 | 1x | $4.01 | 14.71% |
VC Exit Predictor
See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.
Nanopath Comparisons
Industry
Financing
Details
Nanopath Competitors (1)
One of Nanopath’s competitors is Oxford Nanopore Technologies, a Formerly VC-backed company based in Oxford, United Kingdom.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Oxford Nanopore Technologies | Formerly VC-backed | Oxford, United Kingdom |
Nanopath Patents
Nanopath Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| WO-2026024986-A1 | Homogenous deposition of colloidal nanoparticles | Pending | 26-Jul-2024 | ||
| EP-4540609-A2 | Multiplexed pathogen detection using nanoplasmonic sensor for human papillomavirus | Pending | 16-Jun-2022 | ||
| EP-4540609-A4 | Multiplexed pathogen detection using nanoplasmonic sensor for human papillomavirus | Pending | 16-Jun-2022 | ||
| US-20250361572-A1 | Multiplexed pathogen detection using nanoplasmonic sensor for human papillomavirus | Pending | 16-Jun-2022 | ||
| WO-2023245145-A2 | Multiplexed pathogen detection using nanoplasmonic sensor for human papillomavirus | Inactive | 16-Jun-2022 | C12Q1/708 |
Nanopath Signals
Nanopath Investors (20)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Elderberry Ventures | Venture Capital | Minority | ||
| Labcorp Venture Fund | Corporate Venture Capital | Minority | ||
| nCourage Investment Group | Angel Group | Minority | ||
| MassVentures | Venture Capital | Minority | ||
| Medical Device Innovation Consortium | Corporation |
Nanopath FAQs
-
When was Nanopath founded?
Nanopath was founded in 2019.
-
Where is Nanopath headquartered?
Nanopath is headquartered in Cambridge, MA.
-
What is the size of Nanopath?
Nanopath has 29 total employees.
-
What industry is Nanopath in?
Nanopath’s primary industry is Diagnostic Equipment.
-
Is Nanopath a private or public company?
Nanopath is a Private company.
-
What is the current valuation of Nanopath?
The current valuation of Nanopath is .
-
What is Nanopath’s current revenue?
The current revenue for Nanopath is .
-
How much funding has Nanopath raised over time?
Nanopath has raised $46.2M.
-
Who are Nanopath’s investors?
Elderberry Ventures, Labcorp Venture Fund, nCourage Investment Group, MassVentures, and Medical Device Innovation Consortium are 5 of 20 investors who have invested in Nanopath.
-
Who are Nanopath’s competitors?
Oxford Nanopore Technologies is a competitor of Nanopath.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process